[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588847":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":30,"responsibleParty":46,"collaborators":48,"id":62,"slug":19,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":19,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":19,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":19,"overallStatus":33,"whyStopped":19,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"RenJi Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"The Acostream aspiration group","EXPERIMENTAL","The pulmonary thrombus removal by Acostream.",[13],"Device: Acostream aspiration",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":19},"DEVICE","Acostream aspiration",[9],null,[21,26],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Qihong Ni","CONTACT","15801900772","niqihong1989@163.com",{"name":27,"role":23,"phone":28,"phoneExt":19,"email":29},"Meng Ye","13817145123","13817145123@163.com",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Renji Hospital","RECRUITING","Shanghai","Shanghai Municipality","200217","China",{"type":39,"coordinates":40},"Point",[41,42],121.45806,31.22222,{"lat":42,"lon":41},[45],{"name":19,"role":23,"phone":24,"phoneExt":19,"email":25},{"type":47,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[49,51,54,56,58,60],{"name":50,"class":6},"Xiamen Cardiovascular Hospital, Xiamen University",{"name":52,"class":53},"Nantong University Affiliated Hospital","UNKNOWN",{"name":55,"class":6},"Chengdu University of Traditional Chinese Medicine",{"name":57,"class":53},"Shanghai No.1 Hospital",{"name":59,"class":6},"First Affiliated Hospital of Fujian Medical University",{"name":61,"class":6},"Jinhua Central Hospital","100588847",false,"NCT06946732","Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism","Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism (The ARTIST Study)","Inclusion Criteria:\n\n* 18≤Age≤85\n* Clinical symptoms and presentation consistent with pulmonary embolism (PE).\n* PE symptoms duration ≤ 14 days.\n* High risk PE patients with absolute contraindications to systemic thrombolysis or its failure (refractory circulatory collapse) not eligible for surgical embolectomy.\n* Intermediate-high risk PE patients with right ventricle dysfunction (right ventricle\u002F left ventricle \\>0.9) confirmed by computed tomography pulmonary angiography or transthoracic echocardiography.\n\nExclusion Criteria:\n\n* Pregnancy.\n* Refusal to sign the informed consent form.\n* Presence of intracardiac thrombus.\n* Presence of chronic left heart failure with an ejection fraction lower than 30% Diagnosed thrombophilia.\n* History of severe or chronic pulmonary hypertension.\n* Serum creatinine level higher than 1.8 mg\u002Fdl.\n* Known serious and uncontrolled sensitivity to radiographic agents.","ALL","18 Years","85 Years",{"count":72,"type":73},127,"ESTIMATED","INTERVENTIONAL",[76],"NA","The registry is to evaluate the safety and feasibility of catheter-directed aspiration for patients with high-risk and intermediate-high-risk pulmonary embolism using Acostream.",[79],"Pulmonary Embolism (PE)","2025-04-19",{"date":82,"type":83},"2025-04-27","ACTUAL",{"date":85,"type":83},"2025-04-01",{"date":87,"type":73},"2026-12-31",{"name":5,"class":6},1]